Akari Therapeutics (AKTX) Tax Rate (2025 - 2026)

Akari Therapeutics' (AKTX) quarterly Tax Rate came in at 5.61% in Q1 2026, up 444.01% quarter-over-quarter from 1.63% in Q4 2025.

Akari Therapeutics (AKTX) Tax Rate (2025 - 2026) Analysis & Trends

Akari Therapeutics has disclosed Tax Rate across 2 years of filings, most recently posting 5.61% for Q1 2026.

Tax Rate for Q1 2026 came in at 5.61%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 5.97% (changed N/A YoY), and the FY2025 annual result was 5.48%, changed N/A from the prior year.
Tax Rate came in at 5.61% for Q1 2026 at Akari Therapeutics, up from 1.63% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 14.53% in Q3 2025 to a low of 1.63% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-57.14
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-6.79
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	5.61
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	17.68
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Regeneron Pharmaceuticals	63.43 Bn	54.67 Bn	3.31 Bn	12.51

Download Data